High dose titration of calcium channel blocking agents for primary pulmonary hypertension: Guidelines for short-term drug testing

This publication has 15 references indexed in Scilit:

• Widening potential for Ca2+ antagonists: non-L-type Ca2+ channel interaction
  Trends in Pharmacological Sciences, 1990
• The Acute Administration of Vasodilators in Primary Pulmonary Hypertension: Experience from the National Institutes of Health Registry on Primary Pulmonary Hypertension
  American Review of Respiratory Disease, 1989
• Primary pulmonary hypertension. Vascular structure, morphometry, and responsiveness to vasodilator agents.
  Circulation, 1989
• Primary pulmonary hypertension
  Progress in Cardiovascular Diseases, 1988
• Primary Pulmonary Hypertension
  Annals of Internal Medicine, 1987
• High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy.
  Circulation, 1987
• Primary Pulmonary Hypertension
  Medicine, 1986
• The effect of vasodilator therapy on the clinical outcome of patients with primary pulmonary hypertension.
  Circulation, 1985
• Vasodilator Therapy for Primary Pulmonary Hypertension
  Annual Review of Medicine, 1985
• Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease
  Journal of the American College of Cardiology, 1984